Note on Transferable Vouchers – April 2022

Advancing Medicines repurposing in the EU

Repurposing has emerged as an important strategy to address unmet medical need. Yet, there is still significant untapped potential for its application in the EU.

Open

Creating a European ecosystem

Open

Policy recommendations on uptake of biosimilar medicines in the retail market

Policy recommendations on uptake of biosimilar medicines in the retail market (November 2021)

Unlocking the potential of the biosimilar retail market (November 2021)

Retail policy algorithm: Policy recommendations to unlock the potential of the biosimilar retail market Retail policy algorithm – Paper version (November 2021)

Retail policy algorithm: Policy recommendations to unlock the potential of the biosimilar retail market Retail policy algorithm – Interactive version (November 2021)

Eco-Pharmaco-Stewardship (EPS) initiative – Care for People and Our Environment

Open

Open Public Consultation on the revision of EU rules on medicines for children and rare diseases

Open

Factsheet: Removing barriers to equitable access for timely competition

Open

Factsheet: Market and regulatory reforms to ensure availability and resilience of the supply chain

Open

Factsheet: Evaluating the impact of international trade on access to medicines

Open

Factsheet: Boosting affordable innovations

Open